Associated Papers
The Q41R mutation in the HCV-protease enhances the reactivity towards MAVS by suppressing non-reactive pathways.
Zheng C et al.
Physical Chemistry Chemical Physics : Pccp, 2022
In vitro efficacy of approved and experimental antivirals against novel genotype 3 hepatitis C virus subgenomic replicons.
Yu M et al.
Antiviral Research, 2013
Select a paper to view details